AAAAAA

   
Results: 1-10 |
Results: 10
CHALLENGES FACING TECHNOLOGY-ASSESSMENT IN MODERN HEALTH-CARE
Authors: DAVIS KM HEITMANN L KOLLATSCHNY S LESSARD C
Citation: Km. Davis et al., CHALLENGES FACING TECHNOLOGY-ASSESSMENT IN MODERN HEALTH-CARE, IEEE engineering in medicine and biology magazine, 15(5), 1996, pp. 55-59
UPTAKE AND BINDING OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE BY RAW-264.7 CELLS - A 3-STEP PROCESS
Authors: MAKABIPANZU B LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG
Citation: B. Makabipanzu et al., UPTAKE AND BINDING OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE BY RAW-264.7 CELLS - A 3-STEP PROCESS, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 227-235
LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS
Authors: DUSSERRE N LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG
Citation: N. Dusserre et al., LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS, Journal of cellular biochemistry, 1995, pp. 177-177
THE RNA OF BOTH POLARITIES OF THE PEACH LATENT MOSAIC VIROID SELF-CLEAVES IN-VITRO SOLELY BY SINGLE HAMMERHEAD STRUCTURES
Authors: BEAUDRY D BUSSIERE F LAREAU F LESSARD C PERREAULT JP
Citation: D. Beaudry et al., THE RNA OF BOTH POLARITIES OF THE PEACH LATENT MOSAIC VIROID SELF-CLEAVES IN-VITRO SOLELY BY SINGLE HAMMERHEAD STRUCTURES, Nucleic acids research, 23(5), 1995, pp. 745-752
ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS
Authors: DUSSERRE N LESSARD C PAQUETTE N PERRON S POULIN L TREMBLAY M BEAUCHAMP D DESORMEAUX A BERGERON MG
Citation: N. Dusserre et al., ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS, AIDS, 9(8), 1995, pp. 833-841
COMPARISON OF CELLULAR ACCUMULATION, TISSUE DISTRIBUTION, AND ANTI-HIV ACTIVITY OF FREE AND LIPOSOMAL 2',3'-DIDEOXYCYTIDINE
Authors: MAKABIPANZU B LESSARD C PERRON S DESORMEAUX A TREMBLAY M POULIN L BEAUCHAMP D BERGERON MG
Citation: B. Makabipanzu et al., COMPARISON OF CELLULAR ACCUMULATION, TISSUE DISTRIBUTION, AND ANTI-HIV ACTIVITY OF FREE AND LIPOSOMAL 2',3'-DIDEOXYCYTIDINE, AIDS research and human retroviruses, 10(11), 1994, pp. 1463-1470
RAMIFICAITONS OF HEALTH-CARE REFORM ON THE BIOMEDICAL-ENGINEERING COMMUNITY
Authors: GOODE J RASBURY K RICHARDS J LESSARD C
Citation: J. Goode et al., RAMIFICAITONS OF HEALTH-CARE REFORM ON THE BIOMEDICAL-ENGINEERING COMMUNITY, IEEE engineering in medicine and biology magazine, 13(5), 1994, pp. 658-662
A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: KNAPP MJ KNOPMAN DS SOLOMON PR PENDLEBURY WW DAVIS CS GRACON SI APTER JT LAZARUS CN BAKER KE BARNETT M BAUMEL B EISNER LS CASTELLS B BOLOURI R BENNETT D FORCHETTI C LEVIN A BLASS JP NOLAN KA GAINES ER RELKIN N BORISON RL DIAMOND B CELESIA GG ROSS AP DEXTER J DOODY R LIPSCOMB L KREITER K DUBOFF EA BLOCK P MARSHALL D WESTERGAARD N EARL NL WYNE SV HINMANSMITH E FARLOW M HENDRIE HC CARESS JA FARMER M HARPER JE FERGUSON J FOSTER NL BARBAS NR BLUEMLEIN LA GELB DJ BERENT S GIORDANI B GREENWALD M BERGMAN S ROGER LF GROENENDYK A WOOD M JURKOWSKI C KATZ I DOYLE S SMITH BD KELLNER C BERNSTEIN HJ BACHMAN DL KNOPMAN DS DEINARD S LANGLEY L BRIDGES S MARGOLIN RA BURGER MC WISER SL CRENSHAW C MORRIS JC RUBIN EH COATS MA REYES PF BENTZ C DOYLE LL RYMER MM BETTINGER IE LAUBINGER MP SADOWSKY CH MARTINEZ W ZUNIGA J STONE R WINNER P MATE L LESSARD C SCHNEIDER L PAWLUCZYK S SMITH WT LOSK SN MARAMBE L SOLOMON PR PENDLEBURY WW GROCCIAELLISON ME EDWARDS KR TAYLOR J CALABRESE VP HARKINS SW THEIN SG DEWAR JA WILLIAMS G DRENNAN C TUTTLE P PRINCIPI N FORD EM TYNDALL RJ KELLEY CK
Citation: Mj. Knapp et al., A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE, JAMA, the journal of the American Medical Association, 271(13), 1994, pp. 985-991
L-651,392, A POTENT LEUKOTRIENE INHIBITOR, CONTROLS INFLAMMATORY PROCESS IN ESCHERICHIA-COLI PYELONEPHRITIS
Authors: TARDIF M BEAUCHAMP D BERGERON Y LESSARD C GOURDE P BERGERON MG
Citation: M. Tardif et al., L-651,392, A POTENT LEUKOTRIENE INHIBITOR, CONTROLS INFLAMMATORY PROCESS IN ESCHERICHIA-COLI PYELONEPHRITIS, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1555-1560
DAPTOMYCIN MAY ATTENUATE EXPERIMENTAL TOBRAMYCIN NEPHROTOXICITY BY ELECTROSTATIC COMPLEXATION TO TOBRAMYCIN
Authors: COUTURE M SIMARD M GOURDE P LESSARD C GURNANI K LIN LS CARRIER D BERGERON MG BEAUCHAMP D
Citation: M. Couture et al., DAPTOMYCIN MAY ATTENUATE EXPERIMENTAL TOBRAMYCIN NEPHROTOXICITY BY ELECTROSTATIC COMPLEXATION TO TOBRAMYCIN, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 742-749
Risultati: 1-10 |